Quote:

---

Collaboration with a big pharma would provide credibility, probably significant upfront revenue and assets to help with FDA paperwork and discussion. I think it would provide a huge jump in pps and cement the current BOD in their positions. I am thinking Merck but don’t have a firm suspicion of the indication.

---

I think there was a tell in Chess Master's article, as he's paid by Cytodyn to write them. He discussed Big Pharma partnering or even a BO towards the end of the article and, I have to assume, NP signs off on his work.

Gotta wonder if we're finally at the "can't beat them might as well join them stage."